PPARG and metabolic dysfunction-associated steatotic liver disease: PPARγ promotes the activation of anti-inflammatory M2 macrophages while reducing the number of pro-inflammatory M1 macrophages in NAFLD-associated hepatic inflammation [39], suggesting the beneficial role of PPARγ against progression of NAFLD into NASH.